Clinical Cancer Research , Vol. 19, No. 13. , pp. 3640-3648, doi:10.1158/1078-0432.ccr-13-0282 Purpose: A multiple myeloma vaccine has been developed whereby patient-derived tumor cells are fused with autologous dendritic cells, creating a hybridoma that stimulates a broad antitumor response.
http://www.citeulike.org/user/jrifon/article/12457265
http://www.citeulike.org/user/jrifon/article/12457265
No comments:
Post a Comment